| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8743892 | Travel Medicine and Infectious Disease | 2018 | 7 Pages |
Abstract
IXIARO® was generally well tolerated in children, with an overall AE profile similar to adults. IXIARO® was highly immunogenic in both dose groups.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Tomas Jelinek, Michael A. Cromer, Jakob P. Cramer, Deborah J. Mills, Kenneth Lessans, Anthony W. Gherardin, Elizabeth D. Barnett, Stefan H.F. Hagmann, Helena H. Askling, Sigrid Kiermayr, Vera Kadlecek, Susanne Eder-Lingelbach, Christian Taucher,